Prenetics Group Limited (PRE) News

Prenetics Group Limited (PRE): $1.81

-0.04 (-2.17%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter PRE News Items

PRE News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest PRE News From Around the Web

Below are the latest news stories about PRENETICS GLOBAL LTD that investors may wish to consider to help them evaluate PRE as an investment opportunity.

Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the second quarter ended June 30, 2022.

Yahoo | September 9, 2022

The past year for Prenetics Global (NASDAQ:PRE) investors has not been profitable

The simplest way to benefit from a rising market is to buy an index fund. Active investors aim to buy stocks that...

Yahoo | August 12, 2022

Prenetics Launches Circle Snapshot, Simple At-home Blood Tests Using the World's First Push-Button and Painless Blood Collection Device

Prenetics Global Limited (NASDAQ: PRE), a global leader in genomic and diagnostic testing, announced the launch of Circle Snapshot, a variety of at-home blood tests that feature the world's first painless, patented, push-button blood collection device, to enable individuals to discover one's current health status from home.

Yahoo | August 8, 2022

What Kind Of Investors Own Most Of Prenetics Global Limited (NASDAQ:PRE)?

If you want to know who really controls Prenetics Global Limited ( NASDAQ:PRE ), then you'll have to look at the makeup...

Yahoo | July 16, 2022

Prenetics Launches ColoClear, a Non-Invasive Stool DNA Test to Detect Early Signs of Colorectal Cancer in Hong Kong

Prenetics Group Limited (Nasdaq: PRE), a global leader in genomic and diagnostic testing, has introduced a novel, non-invasive, at-home screening test – ColoClear by Circle (ColoClear), for detecting early signs of colorectal cancer. Colorectal cancer is the second most common cancer in Hong Kong, accounting for 15.8% of total new cancers in 2019[1]. Combining advanced stool DNA technology with a faecal immunochemical test (FIT), the revolutionary test is the first line of defense against one of

Yahoo | June 8, 2022

Prenetics Announces First Quarter 2022 Financial Results After a Successful Listing on the Nasdaq under the Ticker "PRE"

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the first quarter ended March 31, 2022. The Company recorded strong operational and financial performance driven by solid diagnostics and genetic testing demand, and is on track to achieve revenue guidance for FY2022.

Yahoo | June 6, 2022

Bad News for Google…Good News for Presearch, Its Blockchain Rival

Ad-based businesses are under serious scrutiny.

Ashley Cassell on InvestorPlace | May 25, 2022

Video Highlights – Covid Testing The English Premier League and Beyond: Join CEOs of Prenetics, Artisan in Fireside Chat

IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with the CEO & Co-Founder of Prenetics Limited and the CEO & Director of Artisan Acquisition […]

Yahoo | May 23, 2022

New Horizon Health Partners with Prenetics in Hong Kong to Launch ColoClear, a Non-Invasive Stool DNA Test to Detect Colon Cancer

New Horizon Health (6606.HK) and Prenetics Group Limited (Nasdaq: PRE, "Prenetics") has announced a strategic partnership to launch ColoClear by Circle (ColoClear), the "First Colorectal Cancer Screening Test approved in China", in Hong Kong, and for its first overseas venture in Southeast Asia. Mr. YeQing Zhu, CEO of New Horizon Health, and Mr. Danny Yeung, CEO and Co-Founder of Prenetics, have conducted joint press conference with nearly 60 mainstream media from Mainland China and Hong Kong.

Yahoo | May 23, 2022

Replay – Covid Testing The English Premier League and Beyond: Join CEOs of Prenetics, Artisan in Fireside Chat

IPO Edge and the Palm Beach Hedge Fund Association hosted a fireside chat with the CEO & Co-Founder of Prenetics Limited and the CEO & Director of Artisan Acquisition […]

Yahoo | May 19, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4337 seconds.